BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 25424790)

  • 1. Methionine enkephalin (MENK) improves lymphocyte subpopulations in human peripheral blood of 50 cancer patients by inhibiting regulatory T cells (Tregs).
    Wang Q; Gao X; Yuan Z; Wang Z; Meng Y; Cao Y; Plotnikoff NP; Griffin N; Shan F
    Hum Vaccin Immunother; 2014; 10(7):1836-40. PubMed ID: 25424790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of stimulating effect on subpopulations of lymphocytes in human peripheral blood by methionine enkephalin with IL-2 and IFN-γ.
    Hua H; Lu C; Li W; Meng J; Wang D; Plotnikoff NP; Wang E; Shan F
    Hum Vaccin Immunother; 2012 Aug; 8(8):1082-9. PubMed ID: 22854663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methionine enkephalin (MENK) inhibits tumor growth through regulating CD4+Foxp3+ regulatory T cells (Tregs) in mice.
    Li X; Meng Y; Plotnikoff NP; Youkilis G; Griffin N; Wang E; Lu C; Shan F
    Cancer Biol Ther; 2015; 16(3):450-9. PubMed ID: 25701137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methionine enkephalin, its role in immunoregulation and cancer therapy.
    Zhao D; Plotnikoff N; Griffin N; Song T; Shan F
    Int Immunopharmacol; 2016 Aug; 37():59-64. PubMed ID: 26927200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methionine enkephalin (MENK) mounts antitumor effect via regulating dendritic cells (DCs).
    Meng Y; Gao X; Chen W; Plotnikoff NP; Griffin N; Zhang G; Shan F
    Int Immunopharmacol; 2017 Mar; 44():61-71. PubMed ID: 28088065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional modulation of the pathway between dendritic cells (DCs) and CD4+T cells by the neuropeptide: methionine enkephalin (MENK).
    Shan F; Xia Y; Wang N; Meng J; Lu C; Meng Y; Plotnikoff NP
    Peptides; 2011 May; 32(5):929-37. PubMed ID: 21335041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Killing effect of methionine enkephalin on melanoma in vivo and in vitro.
    Wang DM; Jiao X; Plotnikoff NP; Griffin N; Qi RQ; Gao XH; Shan FP
    Oncol Rep; 2017 Oct; 38(4):2132-2140. PubMed ID: 28849104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increase in activated Treg in TIL in lung cancer and in vitro depletion of Treg by ADCC using an antihuman CCR4 mAb (KM2760).
    Kurose K; Ohue Y; Sato E; Yamauchi A; Eikawa S; Isobe M; Nishio Y; Uenaka A; Oka M; Nakayama E
    J Thorac Oncol; 2015 Jan; 10(1):74-83. PubMed ID: 25325779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating subsets and CD4(+)CD25(+) regulatory T cell function in chronic inflammatory demyelinating polyradiculoneuropathy.
    Sanvito L; Makowska A; Gregson N; Nemni R; Hughes RA
    Autoimmunity; 2009; 42(8):667-77. PubMed ID: 19886739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pretreatment of human peripheral blood lymphocytes with interleukin-2 or dexamethasone does not alter their response to Met-Enkephalin in a NK-cytotoxic assay.
    Martin-Kleiner I; Gabrilovac J
    Immunopharmacol Immunotoxicol; 1996 Feb; 18(1):37-57. PubMed ID: 8683038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunotherapy of cancer via mediation of cytotoxic T lymphocytes by methionine enkephalin (MENK).
    Li W; Chen W; Herberman RB; Plotnikoff NP; Youkilis G; Griffin N; Wang E; Lu C; Shan F
    Cancer Lett; 2014 Mar; 344(2):212-22. PubMed ID: 24291668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapamycin, unlike cyclosporine A, enhances suppressive functions of in vitro-induced CD4+CD25+ Tregs.
    Bocian K; Borysowski J; Wierzbicki P; Wyzgal J; Klosowska D; Bialoszewska A; Paczek L; Górski A; Korczak-Kowalska G
    Nephrol Dial Transplant; 2010 Mar; 25(3):710-7. PubMed ID: 19903662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Detection of lymphocyte subsets in the peripheral blood of patients with malignant ovarian tumors].
    Liu M; Xie J; Zhao S
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Jun; 30(6):627-9, 634. PubMed ID: 24909286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methionine enkephalin inhibits colorectal cancer by remodeling the immune status of the tumor microenvironment.
    Wang X; Li S; Yan S; Shan Y; Wang X; Jingbo Z; Wang Y; Shan F; Griffin N; Sun X
    Int Immunopharmacol; 2022 Oct; 111():109125. PubMed ID: 35988519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel mechanism of lung cancer inhibition by methionine enkephalin through remodeling the immune status of the tumor microenvironment.
    Zhang S; Huang H; Handley M; Griffin N; Bai X; Shan F
    Int Immunopharmacol; 2021 Oct; 99():107999. PubMed ID: 34315116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increase of regulatory T cells in the peripheral blood of cancer patients.
    Wolf AM; Wolf D; Steurer M; Gastl G; Gunsilius E; Grubeck-Loebenstein B
    Clin Cancer Res; 2003 Feb; 9(2):606-12. PubMed ID: 12576425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methionine enkephalin (MENK) improved the functions of bone marrow-derived dendritic cells (BMDCs) loaded with antigen.
    Li W; Meng J; Li X; Hua H; Yiming M; Wang Q; Wang E; Shan F
    Hum Vaccin Immunother; 2012 Sep; 8(9):1236-42. PubMed ID: 22906944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Thymoglobulin efficiently expands cytokine-induced killer cells in a clinical-grade culture protocol].
    Chen W; Lin D; Jiang Z; Yang Z; Song S; Zhou J; Zhou L; Sun Y; Yu H; Ma D
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Jul; 30(7):681-5, 690. PubMed ID: 25001928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis C virus core protein triggers expansion and activation of CD4(+)CD25(+) regulatory T cells in chronic hepatitis C patients.
    Zhai N; Chi X; Li T; Song H; Li H; Jin X; Crispe IN; Su L; Niu J; Tu Z
    Cell Mol Immunol; 2015 Nov; 12(6):743-9. PubMed ID: 25531392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Foxp3(high) and Foxp3(low) Treg cells differentially correlate with T helper 1 and natural killer cells in peripheral blood.
    Lee SK; Kim JY; Jang BW; Hur SE; Na BJ; Lee M; Fukui A; Gilman-Sachs A; Kwak-Kim J
    Hum Immunol; 2011 Aug; 72(8):621-6. PubMed ID: 21600259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.